Literature DB >> 19728160

The classification systems of the EQ-5D, the HUI II and the SF-6D: what do they have in common?

Uwe Konerding1, Jörn Moock, Thomas Kohlmann.   

Abstract

PURPOSE: EQ-5D, HUI II and SF-6D often produce very different valuations for the same health state. This paper aims at clarifying to what extent this might be caused by differences between the multi-attribute classification systems belonging to these instruments.
METHODS: Subjects were 264 patients of rehabilitation clinics in Mecklenburg-Western Pomerania (44.3% female; mean age 49.1) who completed the EQ-5D, the HUI II and the SF-36 (the basis of the SF-6D). After scaling with principal component analyses for categorical data, each attribute of each classification system was regressed on the classification systems of the other two instruments, and all attributes together were subjected to ordinary principal component analysis with varimax rotation.
RESULTS: Adjusted multiple R(2) for regression analyses ranged from 0.01 to 0.57. The HUI II attribute 'sensation' and the SF-6D attribute 'role limitation' are virtually unrelated to the remainder. All other attributes of all three instruments can be predicted by each other. EQ-5D and HUI II focus distinctly more on physical functioning than SF-6D.
CONCLUSION: Although all three classification systems have a lot in common, they differ so much that EQ-5D, HUI II and SF-6D would produce different valuations even if these valuations were determined according to the same principle.

Entities:  

Mesh:

Year:  2009        PMID: 19728160     DOI: 10.1007/s11136-009-9525-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  58 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  A community-based study of scaling assumptions and construct validity of the English (UK) and Chinese (HK) SF-36 in Singapore.

Authors:  J Thumboo; K Y Fong; D Machin; S P Chan; K H Leon; P H Feng; S T Thio; M L Boe
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 3.  A comparative review of four preference-weighted measures of health-related quality of life.

Authors:  Jacek A Kopec; Kevin D Willison
Journal:  J Clin Epidemiol       Date:  2003-04       Impact factor: 6.437

Review 4.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

5.  A comparison of the quality of life of hearing-impaired people as estimated by three different utility measures.

Authors:  Garry R Barton; John Bankart; Adrian C Davis
Journal:  Int J Audiol       Date:  2005-03       Impact factor: 2.117

6.  Measuring health-related utility: why the disparity between EQ-5D and SF-6D?

Authors:  Stirling Bryan; Louise Longworth
Journal:  Eur J Health Econ       Date:  2005-09

7.  Do the SF-36 and WHOQOL-BREF measure the same constructs? Evidence from the Taiwan population*.

Authors:  I-Chan Huang; Albert W Wu; Constantine Frangakis
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

8.  The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  J E Ware; M Kosinski; B Gandek; N K Aaronson; G Apolone; P Bech; J Brazier; M Bullinger; S Kaasa; A Leplège; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

9.  The Argentine-Spanish SF-36 Health Survey was successfully validated for local outcome research.

Authors:  Federico A Augustovski; Gabriela Lewin; Ezequiel García-Elorrio; Adolfo Rubinstein
Journal:  J Clin Epidemiol       Date:  2008-09-10       Impact factor: 6.437

10.  Diabetes-specific or generic measures for health-related quality of life? Evidence from psychometric validation of the D-39 and SF-36.

Authors:  I-Chan Huang; Chyng-Chuang Hwang; Ming-Yen Wu; Wender Lin; Walter Leite; Albert W Wu
Journal:  Value Health       Date:  2008 May-Jun       Impact factor: 5.725

View more
  6 in total

1.  Framing of mobility items: a source of poor agreement between preference-based health-related quality of life instruments in a population of individuals receiving assisted ventilation.

Authors:  Liam M Hannan; David G T Whitehurst; Stirling Bryan; Jeremy D Road; Christine F McDonald; David J Berlowitz; Mark E Howard
Journal:  Qual Life Res       Date:  2017-03-02       Impact factor: 4.147

2.  Health state descriptions, valuations and individuals' capacity to walk: a comparative evaluation of preference-based instruments in the context of spinal cord injury.

Authors:  David G T Whitehurst; Nicole Mittmann; Vanessa K Noonan; Marcel F Dvorak; Stirling Bryan
Journal:  Qual Life Res       Date:  2016-04-20       Impact factor: 4.147

3.  Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients.

Authors:  Carlos K H Wong; Elegance T P Lam; Cindy L K Lam
Journal:  Qual Life Res       Date:  2013-04-06       Impact factor: 4.147

4.  Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.

Authors:  Sanjeewa Kularatna; Joshua Byrnes; Yih Kai Chan; Chantal F Ski; Melinda Carrington; David Thompson; Simon Stewart; Paul A Scuffham
Journal:  Qual Life Res       Date:  2017-08-01       Impact factor: 4.147

Review 5.  Is Health Related Quality of Life (HRQoL) a valid indicator for health systems evaluation?

Authors:  Martin Romero; David Vivas-Consuelo; Nelson Alvis-Guzman
Journal:  Springerplus       Date:  2013-12-11

6.  The validity of the EQ-5D-3L items: an investigation with type 2 diabetes patients from six European countries.

Authors:  Uwe Konerding; Sylvia G Elkhuizen; Raquel Faubel; Paul Forte; Tomi Malmström; Elpida Pavi; M F Bas Janssen
Journal:  Health Qual Life Outcomes       Date:  2014-12-05       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.